ADIPOQ and polycystic ovary syndrome: The meta-analysis revealed that metformin treatment was associated with a significant increases in serum adiponectin concentrations in the patients with PCOS, with a corresponding SMD of -0.43 (95% CI: -0.75 to -0.11, P<0.05) (Fig 2).